Immediate Impact

55 standout
Sub-graph 1 of 18

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Thiazolidine-2,4-dione derivatives as potential α-glucosidase inhibitors: Synthesis, inhibitory activity, binding interaction and hypoglycemic activity
2024 Standout
2 intermediate papers

Works of Benjamin A. Thuma being referenced

Development of an Early-Phase Bulk Enabling Route to Sodium-Dependent Glucose Cotransporter 2 Inhibitor Ertugliflozin
2014
On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin
2012

Author Peers

Author Last Decade Papers Cites
Benjamin A. Thuma 38 25 4 20 5 72
Catherine A. Hulford 40 16 2 10 4 59
R. K. Brown 21 65 5 25 9 185
Wen-Ching Han 108 54 19 14 7 179
C. S. Hudson 60 43 4 20 8 99
Edward C. Kendall 48 60 8 68 16 167
Kevin F. McGee 162 82 5 35 12 245
I. M. Heilbron 50 68 7 4 4 126
Caesar R. Scholz 62 43 6 13 6 102
Annie Pullockaran 92 43 9 21 6 115
Charles E. Carter 38 165 14 9 7 216

All Works

Loading papers...

Rankless by CCL
2026